CMS - Centers for Medicare & Medicaid Services

07/01/2026 | Press release | Distributed by Public on 07/01/2026 08:01

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications

Eligible Medicare beneficiaries may now get certain GLP-1 medications for $50 per month through the Medicare GLP-1 Bridge, a new Centers for Medicare & Medicaid Services (CMS) initiative designed to expand access to innovative treatments and test the impacts of increased access to GLP-1 drugs for weight management on the Medicare program.

Through the Medicare GLP-1 Bridge, eligible individuals enrolled in Medicare Part D prescription drug coverage can obtain certain GLP-1 medications to lose weight or maintain weight reduction at a predictable and affordable cost of $50 per month. The initiative will remain available through December 31, 2027, and reflects CMS' continued focus on improving access to innovative treatments that support better long-term health outcomes.

"For too long, many Americans have been unable to access these treatments because of cost," said CMS Administrator Dr. Mehmet Oz. "The Medicare GLP-1 Bridge creates a new pathway for eligible beneficiaries to afford GLP-1 medications. If you think a GLP-1 medication may be right for you, talk with your doctor and learn whether you qualify."

Medicare beneficiaries interested in learning whether they qualify for the Medicare GLP-1 Bridge should visit Medicare.gov/glp1bridge and talk with their doctor about whether a GLP-1 medication may be right for them.

Not all Medicare beneficiaries will qualify for the Medicare GLP-1 Bridge, including individuals who already receive GLP-1 medications through their existing Medicare prescription drug coverage or are eligible for GLP-1 coverage through the Medicare Part D benefit.

CMS also has released resources for prescribers and pharmacies to support Medicare GLP-1 Bridge implementation. These materials, along with eligibility information and details about the initiative, are available at https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge .

The Medicare GLP-1 Bridge builds on CMS' broader efforts to improve access to innovative therapies and support healthier outcomes for Medicare beneficiaries.

###

Get CMS news at cms.gov/newsroom , sign up for CMS news via email and follow CMS on X @CMSgov

CMS - Centers for Medicare & Medicaid Services published this content on July 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 01, 2026 at 14:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]